# SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma

> clinical trial · VERIFIED · 2026-07-28

Status: ACTIVE_NOT_RECRUITING · Sponsor: Dana-Farber Cancer Institute · Condition: Acute Lymphoblastic Leukemia

- Company: Dana-Farber Cancer Institute
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT01574274

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.